Tuberculosis News and Research

Latest Tuberculosis News and Research

Protein research may help develop new antibiotics

New findings about a protein that keeps cells alive by opening and closing pores within a cell's membrane may open the door to the development of new antibiotics.

30 Jun 2004

New £18M Medical Research Council facility

A new £18M Medical Research Council (MRC) facility to understand and compare the genetics of disease in mice and humans will be opened today, Wednesday 30 June, by Lord Sainsbury, Minister for Science and Technology.

29 Jun 2004

Bush outlines government actions on HIV/AIDS

President Bush visited Philadelphia, Pennsylvania last week, to discuss the need for providing treatment to Americans living with HIV/AIDS, and to highlight the work of faith-based and community organizations as they seek to treat and care for Americans living with HIV/AIDS.

26 Jun 2004

Latin America and the Caribbean lead the developing world in providing HIV/AIDS treatment

Today Latin America and the Caribbean lead the developing world in providing HIV/AIDS treatment, accounting for more than half of all people on antiretrovirals in developing countries

25 Jun 2004

2000 Ukrainian patients to receive treatment for HIV/AIDS

A contract, worth 3,6 million dollars, was signed between the two parties, for the delivery of multi-source antiretrovirals in 2004.

22 Jun 2004

Secrecy about HIV in Nigerian Navy could be fueling AIDS epidemic

They believe that secrecy about AIDS-related deaths, and multiple sex partnering in the Nigerian navy could be helping to fuel the HIV epidemic in Nigeria, Africa’s most populated country.

21 Jun 2004

Latin America and the Caribbean lead the developing world in providing HIV/AIDS treatment

Today Latin America and the Caribbean lead the developing world in providing HIV/AIDS treatment, accounting for more than half of all people on antiretrovirals in developing countries, according to the Pan American Health Organization (PAHO).

15 Jun 2004

U.S. team to battle malaria in Peru

In the middle of the Peruvian Amazon, a battle against malaria – the second largest killer of people worldwide – will be undertaken by an international team of researchers led by tropical disease specialist Joseph Vinetz, M.D., from the University of California, San Diego (UCSD) School of Medicine.

11 Jun 2004

Expert to help WHO in Dili, East Timor with tropical diseases

A JCU public health expert is off to Dili, Timor Leste (formerly East Timor) to help the World Health Organisation address three serious tropical diseases: lymphatic filariasis, intestinal worms and yaws.

10 Jun 2004

Advertising restrcitions on some over the counter medicines likely to be lifted

Regulations to remove the current ban on advertising certain over the counter (OTC) medicines to the public were laid in Parliament today

9 Jun 2004

150 top scientists debate and offer expert advice on cutting edge vaccine research

More than 150 top scientists, researchers and public health experts from around the world will meet in Switzerland next week to present, debate and offer expert advice on cutting edge vaccine research and development, as well as vaccine policy and implementation.

3 Jun 2004

Ethiopia needs external help fighting the HIV/AIDS pandemic

Ethiopia has taken crucial steps to fight the HIV/AIDS pandemic, but the east African country urgently needs external assistance if its efforts are to meet with success, a senior United Nations official said today.

2 Jun 2004

Tuberculosis test kits order

Medical Services International Inc.has announced that it has received its first order for the VScan Tuberculosis (TB) rapid test kit from a prominent pharmaceutical company that produces Tuberculosis vaccines.

2 Jun 2004

Malaria, Africa's biggest killer

It's Africa's biggest killer, but it's not HIV. It causes economic losses of US$12 billion per year, but it's not a war. And it has slowed African economic growth by around 1.3 per cent per annum, but it’s not a famine.

2 Jun 2004

Myth of disease threat posed by dead bodies after natural disasters unfounded

Fears that dead bodies will spread infection and disease following natural disasters are largely baseless, and simply serve to prolong the suffering of surviving friends and family members, according a scientific article published today.

1 Jun 2004

Innovative technique for rapid tuberculosis detection

NTU develops innovative technique for rapid tuberculosis detection Tuberculosis (TB) detection in the future will become faster, cheaper and easier using an innovative TB detection technique and device developed by Nanyang Technological University (NTU).

30 May 2004

Weekly cycles of once-daily anti-HIV drugs could reduce cost of HIV treatment

In a small study conducted at the U.S. National Institutes of Health (NIH), researchers have shown that it may be feasible to treat HIV-infected patients with a simple, once-daily regimen of anti-HIV drugs given in pre-planned, 7-day-on, 7-day-off cycles.

24 May 2004

Positive Chinese results for HIV test kit

Medical Services International Inc. has announced that it has received additional test results from the People's Republic of China related to its VScan HIV test kit. The results of an additional 1200 tests show that the test kit had a sensitivity of 99.4% and a specificity of 99.9%.

21 May 2004

Canadian Statement to the World Health Assembly focuses on AIDS

The WHO's leadership is particularly important in the fight to combat HIV/AIDS. Last week, Canada bolstered its financial commitment to this effort with contributions of $100 million for WHO's '3 by 5 initiative', and $70 million to the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria. Canada and Canadians are proud to take these actions against HIV/AIDS.

19 May 2004

Study comparing the efficacy of REMICADE® to Azathioprine alone and in combination With REMICADE®

Centocor, Inc., and Schering-Plough Corporation announced today the initiation of the SONIC (Study of Immunomodulator Naive patients in Crohn's Disease) trial that will evaluate the efficacy of REMICADE® (infliximab) versus azathioprine, a conventional immunosuppressive agent, alone and versus the combination of both drugs for the treatment of patients with Crohn's disease.

18 May 2004